Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | ANPEP | P15144 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.30 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27458283 | 0.96 | TSHR (0.39) | TSHRALDH1A1MAPK1ANPEPTDP1 | |
| SCHEMBL7869441 | 0.82 | — | — | |
| SCHEMBL7875857 | 0.82 | — | — | |
| SCHEMBL28929421 | 0.82 | ALDH1A1 (0.32) | TSHRALDH1A1MAPK1 | |
| SCHEMBL30843791 | 0.80 | — | — | |
| SCHEMBL9052553 | 0.79 | — | — | |
| SCHEMBL50415 | 0.79 | — | — | |
| SCHEMBL22373330 | 0.79 | ALDH1A1 (0.33) | TSHRALDH1A1MAPK1LMNA | |
| SCHEMBL28661239 | 0.79 | — | — | |
| SCHEMBL8956767 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059876-A | Substituted quinoline compound, preparation method thereof, weeding composition and application | 青岛清原化合物有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-119977897-A | Triazine ring substituted phenylsulfonylurea compound, preparation method thereof, weeding composition and application | 青岛清原化合物有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119431340-A | Substituted nitrogen-containing heterocyclic carboxylic ester compound, preparation method thereof, weeding composition and application | 青岛清原化合物有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-118772105-A | Triazole compound, preparation method thereof, weeding composition and application | 青岛清原化合物有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-118666811-A | Substituted pyrrolidone compound and preparation method, composition and application thereof | 青岛清原化合物有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118530217-A | Pyrimidine ring substituted aromatic compound, preparation method thereof, weeding composition and application | 青岛清原化合物有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-118515618-A | Benzene ring substituted pyrimidine carboxylic acid compound, preparation method thereof, weeding composition and application | 青岛清原化合物有限公司 | 2024-08-20 | — | — | CN | disclosed |
| CN-118496201-A | Substituted pyrrolidone compound and preparation method thereof, weeding composition and application | 青岛清原化合物有限公司 | 2024-08-16 | — | — | CN | disclosed |
| CN-112219853-B | Weeding composition | 江苏龙灯化学有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-116897942-A | Weeding composition containing florasulam and fluroxypyr-meptyl and application thereof | 青岛恒宁生物科技有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116715579-A | Continuous preparation method of isooctyl 2-methyl-4-chlorophenoxyacetate | 江苏永泰丰作物科学有限公司 | 2023-09-08 | — | — | CN | disclosed |
| EP-2945932-B1 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | ALLERGAN INC (US) | 2018-11-21 | — | — | EP | disclosed |
| US-9394284-B2 | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response | ALLERGAN, INC. (US) | 2016-07-19 | — | — | US | disclosed |
| EP-2945932-A1 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | ALLERGAN, INC. (US) | 2015-11-25 | — | — | EP | disclosed |
| US-20150080446-A1 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | ALLERGAN, INC. | 2015-03-19 | — | — | US | disclosed |
| US-8859606-B2 | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response | ALLERGAN, INC. (US) | 2014-10-14 | — | — | US | disclosed |
| WO-2014113814-A1 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | ALLERGAN, INC. (US) | 2014-07-24 | — | — | WO | disclosed |
| US-20130131135-A1 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | ALLERGAN, INC. (US) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080446-A1 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | PTGER1, PTGER4, CNR1 | TSHR 420/4885ALDH1A1 775/4885MAPK1 521/4885 |
| US-20130131135-A1 | COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE | PTGER1, PTGER4, CNR1 | TSHR 420/4885ALDH1A1 775/4885MAPK1 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.